Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Immuron Ltd Regulatory Filings 2009

Feb 22, 2009

35121_rns_2009-02-22_bffe0119-f837-4887-84da-117e428d8992.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Immuren

23 February 2009

The Manager The Company Announcement Office Australian Stock Exchange Limited Sydney NSW

Dear Sir

Immuron Limited

We attach an announcement in respect of a visit to Australia by Professor Yaron Ilan from the Hadassah Medical Organisation (Hadassah), Israel, and the strategic alliance being developed between Hadassah and Immuron Limited.

Yours faithfully Graeme Stevens Company Secretary

ABN 80 063 114 045 AUSTRALIA Level 1, 39 Leveson Street North Melbourne VIC 3051 Tel (61) 3 9018 4880 Fax (61) 3 9018 4881

USA The Empire State Building 350 Fifth Avenue 59th Floor New York, N.Y. 10118 Tel 646 402 5289 Fax 646 390 3238

www.immuron.com www.travelan.com

i.

Immuron

23 February 2009

Immuron Ltd, the Australian -based biopharmaceuticals company specializing in the manufacturing of orally delivered polyclonal antibodies for treatment of infectious and chronic diseases, announces that it is continuing its negotiations on its strategic alliance with Hadasit Research Services & Development Limited, the commercialization arm of the Hadassah Medical Organization, Israel, in respect of utilizing Hadassah's intellectual property in expanding the results obtained from the preclinical work conducted by Hadassah utilizing Immuron's hyper immune colostrum.

As previously announced, the research is addressing a number of medical indications. including Type II diabetes and metabolic syndrome, conditions which are not adequately addressed with existing therapy.

Professor Yaron Ilan, MD, of Hadassah is currently visiting Australia to discuss his research findings.

Contact

Dr Oren Fuerst - VP Business Development

Email: [email protected]

Tel +1 646 259 3321

Arie Nudel - Investor Relations

Email: [email protected]

Tel + 61 3 9018 4880

ABN 80 063 114 045 AUSTRALIA Level 1, 39 Leveson Street North Melbourne VIC 3051 Tel (61) 3 9018 4880 Fax (61) 3 9018 4881

USA The Empire State Building 350 Fifth Avenue 59th Floor New York, N.Y. 10118 Tel 646 402 5289 Fax 646 390 3238

www.immuron.com www.travelan.com